The pharmacologically or genetically induced Nrf2 activity clearly decreased right ventricular hypertrophy (RVH) and pulmonary vascular remodeling in the hypoxic pH model [47]. The gene discussed is NFE2L2; the disease is Right ventricular hypertrophy.